Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kentuckiana Cancer Institute (KCI) was a specialized oncology and hematology medical practice and clinical research center located in Louisville, Kentucky. Founded by Dr. Renato V. La Rocca, the institute was a leading community-based site for Phase I through Phase IV clinical trials, collaborating with major pharmaceutical companies to evaluate novel cancer therapies. KCI provided comprehensive patient care, including chemotherapy, immunotherapy, and advanced diagnostic services for a wide range of malignancies such as glioblastoma and lung cancer. In January 2012, the institute merged with Norton Cancer Institute, a part of Norton Healthcare, to consolidate oncology resources and enhance research capabilities in the region. Following the merger, its clinical operations were integrated into the Norton Healthcare system, while its research legacy is maintained through the Kentuckiana Cancer Research Foundation (KCRF). KCI was instrumental in bringing cutting-edge clinical research to the local patient population in the Kentuckiana area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kentuckiana Cancer Institute.